Kenya’s Consumers Federation of Kenya (COFEK) has filed a constitutional petition challenging the legitimacy of a “KNDI Endorsed” seal on products like Weetabix cereals and Brookside dairy. The seal, appearing on packaging nationwide, has sparked legal action alleging it misleads consumers by mimicking the appearance of the Kenya Bureau of Standards’ official Diamond Mark.
Legal Basis of the Dispute
COFEK argues that the Kenya Nutritionists and Dieticians Institute (KNDI) lacks statutory authority to certify food products. KNDI, established under the Nutritionists and Dieticians Act, regulates nutrition professionals, not food labeling. That responsibility lies with the Kenya Bureau of Standards (KEBS), which operates the Diamond Mark scheme.
The petition claims the KNDI seal exploits the visual credibility of KEBS’s mark, creating false consumer impressions of government endorsement. Weetabix’s adoption of the seal reportedly began in March 2023, with KNDI collecting fees from participating manufacturers while ignoring unlabeled products from competitors.
Regulatory Conflict and Timeline
The dispute intensified through a series of official communications. COFEK alerted Health Cabinet Secretary Aden Duale on July 15, demanding an audit of all marked products. Follow-up letters on July 21 demanded Weetabix withdraw the seal and disclose any payments. Duale responded on July 22, ordering KNDI’s CEO to justify the mark within seven days.
KNDI refused on July 23, citing a “97.35 percent wholesomeness score” and threatening litigation against COFEK for harassment. Weetabix’s lawyers rejected withdrawal demands on July 30. They filed suit on August 3. Justice Gregory Mutai granted urgent hearing status, with a compliance mention scheduled for September 24, 2026.
Specific Legal Remedies Sought
The petition requests thirteen remedies, including a declaration that the endorsement scheme is unconstitutional and ultra vires (beyond KNDI’s legal authority). It seeks certiorari to quash the scheme, an injunction barring KNDI from future endorsements, and orders preventing Weetabix and Brookside from claiming official endorsement.
Read Also: Counties struggle to pay salaries amid budget clearance delays
COFEK also demands a government-wide review of product-endorsement frameworks. Additional requests include auditing KNDI’s finances by the Auditor-General and addressing the CEO’s extended tenure—nearly two decades against the four-year renewable term specified in law.
Broader Implications for Kenyan Regulation
The case highlights a recurring issue in Kenya’s regulatory environment: statutory bodies monetizing commercially valuable activities outside their founding mandates. Consumers indirectly bear costs through higher prices for “endorsed” products. COFEK’s litigation highlights gaps in Kenya’s consumer protection infrastructure.
While the Consumer Protection Act (Sections 12 and 13) prohibits deceptive practices, Kenya lacks a dedicated advertising regulator like the UK’s Advertising Standards Authority, which can issue swift injunctions. This absence compels disputes to escalate to constitutional courts rather than being resolved through administrative channels.
International Comparisons
Kenya’s approach mirrors global efforts to curb deceptive endorsements. The U.S. Federal Trade Commission’s Endorsement Guides mandate truthful, substantiated claims reflecting actual endorsement authority. The European Union’s Unfair Commercial Practices Directive bans unverified approval claims, while its food law restricts nutrition labels to scientifically authorized assertions.
The UK’s CAP Code similarly requires verifiable basis for official endorsement claims. South Africa’s Consumer Protection Act (2008) empowers its National Consumer Commission to enforce against false representations without constitutional litigation. These frameworks offer faster remedies than Kenya’s current process, suggesting systemic reform may be necessary to align with international standards.
